Literature DB >> 8603257

Development of vaginal microbicides for the prevention of heterosexual transmission of HIV.

R Pauwels1, E De Clercq.   

Abstract

Various compounds could be considered to be vaginal microbicides, preventing heterosexual transmission of HIV (i.e. virucidal agents such as nonoxynol 9 and chlorhexidine) and antiviral agents interfering with either virus adsorption/fusion [polyanionic substances such as polysulfates (i.e. PVAS, PAVAS), polysulfonates, polycarboxylates, polyoxometalates and negatively charged albumins], or fusion/uncoating (bicyclams), or reverse transcription [dideoxynucleoside analogues, acyclic nucleoside phosphonates such as PMEA and PMPA, and non-nucleoside reverse transcriptase inhibitors (NNRTIs) such as TIBO, HEPT, and alpha-APA derivatives]. In particular, combination of two or more of these compounds seems to be an attractive approach to interrupt transmission of HIV at different stages of the infectious process.

Mesh:

Substances:

Year:  1996        PMID: 8603257     DOI: 10.1097/00042560-199603010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  17 in total

1.  Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations.

Authors:  D L Patton; Y T Cosgrove Sweeney; J E Balkus; L C Rohan; B J Moncla; M A Parniak; S L Hillier
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

Review 2.  Vaginal drug delivery systems for HIV prevention.

Authors:  Lisa Cencia Rohan; Alexandra B Sassi
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

3.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

4.  ART-RRT: As-Rigid-As-Possible search for protein conformational transition paths.

Authors:  Minh Khoa Nguyen; Léonard Jaillet; Stéphane Redon
Journal:  J Comput Aided Mol Des       Date:  2019-08-21       Impact factor: 3.686

Review 5.  The repertoire of human efforts to avoid sexually transmissible diseases: past and present. Part 2: Strategies used during or after sex.

Authors:  B Donovan
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

6.  The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitro.

Authors:  P B Wyrick; S T Knight; D G Gerbig; J E Raulston; C H Davis; T R Paul; D Malamud
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.

Authors:  Lin Li; Pengyuan Qiao; Jie Yang; Lu Lu; Suiyi Tan; Hong Lu; Xiujuan Zhang; Xi Chen; Shuguang Wu; Shibo Jiang; Shuwen Liu
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

Review 8.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

9.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

10.  RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Authors:  Yonghou Jiang; Baoping Tian; Mohammed Saifuddin; Michael B Agy; Peter Emau; J Scott Cairns; Che-Chung Tsai
Journal:  AIDS Res Ther       Date:  2009-11-05       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.